Amphastar Pharmaceuticals, Inc.
AMPH
$28.81
$0.491.73%
| Weiss Ratings | AMPH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | B | |||
| Rating Factors | AMPH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Excellent | |||
| Efficiency Index | Excellent | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | AMPH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.96 | |||
| Price History | AMPH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -7.69% | |||
| 30-Day Total Return | -20.83% | |||
| 60-Day Total Return | -34.22% | |||
| 90-Day Total Return | -41.95% | |||
| Year to Date Total Return | -20.76% | |||
| 1-Year Total Return | -38.39% | |||
| 2-Year Total Return | -18.39% | |||
| 3-Year Total Return | -6.28% | |||
| 5-Year Total Return | 97.87% | |||
| 52-Week High % Change | -47.51% | |||
| 52-Week Low % Change | 4.97% | |||
| Price | AMPH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $53.96 | |||
| 52-Week Low Price | $26.98 | |||
| 52-Week Low Price (Date) | Mar 03, 2025 | |||
| 52-Week High Price (Date) | Nov 06, 2024 | |||
| Valuation | AMPH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 1.35B | |||
| Enterprise Value | 1.78B | |||
| Price/Earnings (TTM) | 9.26 | |||
| Earnings Per Share (TTM) | 3.06 | |||
| Earnings Per Share Growth | 18.13% | |||
| Price/Earnings To Growth | 0.51 | |||
| Price/Sales (TTM) | 1.99 | |||
| Price/Book (Q) | 1.84 | |||
| Enterprise Value/Revenue (TTM) | 2.43 | |||
| Price | $28.81 | |||
| Enterprise Value/EBITDA (TTM) | 6.88 | |||
| Enterprise Value/EBIT | 8.66 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | AMPH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 51.31M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | AMPH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 909 980 9484 | |||
| Address | 11570 6th Street Rancho Cucamonga, CA 91730 | |||
| Website | www.amphastar.com | |||
| Country | United States | |||
| Year Founded | 1996 | |||
| Profitability | AMPH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 28.06% | |||
| Profit Margin | 21.79% | |||
| Management Effectiveness | AMPH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 8.31% | |||
| Return on Equity | 23.26% | |||
| Income Statement | AMPH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 712.81M | |||
| Total Revenue (TTM) | 731.97M | |||
| Revenue Per Share | $14.27 | |||
| Gross Profit (TTM) | 373.86M | |||
| EBITDA (TTM) | 258.39M | |||
| EBIT (TTM) | 205.42M | |||
| Net Income (TTM) | 159.52M | |||
| Net Income Avl. to Common (TTM) | 159.52M | |||
| Total Revenue Growth (Q YOY) | 4.73% | |||
| Earnings Growth (Q YOY) | 4.97% | |||
| EPS Diluted (TTM) | 3.06 | |||
| EPS Diluted Growth (Q YOY) | 7.17% | |||
| Balance Sheet | AMPH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 221.65M | |||
| Cash Per Share (Q) | $4.32 | |||
| Total Current Assets (Q) | 534.07M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 732.30M | |||
| Current Ratio (Q) | 3.074 | |||
| Book Value Per Share (Q) | $15.38 | |||
| Total Assets (Q) | 1.58B | |||
| Total Current Liabilities (Q) | 173.76M | |||
| Total Debt (Q) | 650.55M | |||
| Total Liabilities (Q) | 845.17M | |||
| Total Common Equity (Q) | 732.30M | |||
| Cash Flow | AMPH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -124.93M | |||
| Cash from Financing (TTM) | -80.95M | |||
| Net Change in Cash (TTM) | 7.31M | |||
| Levered Free Cash Flow (TTM) | 15.64M | |||
| Cash from Operations (TTM) | 213.39M | |||
